June 16, 2021 -- Medidata has launched an end-to-end unified platform for the decentralization of clinical trials.
The company's Decentralized Clinical Trials Program unifies direct patient data capture technology with study oversight and monitoring, offering a high level of customization and enabling fully decentralized and hybrid studies.
The program captures data remotely, then aggregates and transforms that data, monitors it to identify quality issues, and runs analytics to gain insight into better outcomes for patients, researchers, sponsors, and contract research organizations.